An artificial intelligence (AI)-designed small molecule that targets the NR3C1 gene may offer a safer, more effective treatment for Cushing’s syndrome by counteracting excess cortisol. Insilico Medicine said it will focus on its molecule, ISM6200, as a promising new drug that may become a leading treatment for ovarian cancer,…